ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE, USE OF ANIONICALLY MODIFIED POLYALLYLAMINE DERIVATIVE AS MEDICINE, PARTICULARLY FOR PROPYLAXIS AND TREATMENT OF INFECTIONS OF RESPIRATORY TRACT CAUSED BY HUMAN METAPNEUMOVIRUS (HMPV), HUMAN RHINOVIRUSES (HRV), AND INFECTION BY INFLUENZA VIRUS TYPE A (IAV) AND PHARMACEUTICAL COMPOSITION COMPRISING THE...
NOWAKOWSKA, MARIA,SZCZUBIALKA, KRZYSZTOF,PYRC, KRZYSZTOF,CIEJKA, JUSTYNA,WYTRWAL, MAGDALENA,MILEWSKA, ALEKSANDRA
申请号：
CA2955406
公开号：
CA2955406A1
申请日:
2015.07.29
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
An N-sulfonic polyallylamine derivative (NSPAH) with Formula 1 wherein R is -SO3- or -H, and n is an integer from 150 to 15000, and at least one R is -SO3-. An application of the NSPAH as a medicine, particularly for prevention and treatment of respiratory tract infections caused by the human metapneumovirus (hMPV), respiratory tract infections caused by the human rhinoviruses (HRV), and infections caused by the influenza A virus. A pharmaceutical composition comprising the NSPAH as an active substance and the application thereof.
